Browse Category

Financial Updates News 11 November 2025 - 14 November 2025

Meta’s Q3 Showdown: Can AI Spend and Ad Growth Drive Another Rally?

Meta Stock Today, November 14, 2025: Tiger Global Exit, AI Spending Fears and Scam-Ad Revelations Leave META Flat

Meta Platforms (NASDAQ: META) ended Friday’s session almost unchanged despite a barrage of headlines about hedge-fund selling, AI-fueled spending plans, new data centers and fresh scrutiny of its ad business. The stock closed around $609.46, giving the company a market value of roughly $1.5 trillion. That leaves META about 23% below its August peak near $790, but still roughly 27% above its 52‑week low…
Cytek Biosciences (CTKB) Stock Pops in Choppy Market After String of Positive Catalysts – November 14, 2025

Cytek Biosciences (CTKB) Stock Pops in Choppy Market After String of Positive Catalysts – November 14, 2025

On Friday, November 14, 2025, Cytek Biosciences, Inc. (NASDAQ: CTKB) is trading sharply higher, extending a strong two‑week run helped by fresh industry recognition, product awards and steady (if modest) earnings growth. As of the latest trade this afternoon, CTKB is changing hands around $4.99, up roughly 9% intraday, with the stock appearing on Nasdaq’s list of notable movers even…
Hims & Hers Health (HIMS) Stock Falls as New ‘Labs’ Platform With Quest Diagnostics Launches – November 14, 2025 Update

Hims & Hers Health (HIMS) Stock Falls as New ‘Labs’ Platform With Quest Diagnostics Launches – November 14, 2025 Update

Hims & Hers Health, Inc. (NYSE: HIMS) is in the spotlight today after officially rolling out its new “Labs” diagnostic platform in partnership with Quest Diagnostics, even as the stock trades sharply lower and Wall Street sentiment turns more cautious. The telehealth company is trying to push deeper into preventive, data-led healthcare at the same time investors are digesting rich…
IREN Limited (IREN) Stock Plunges 12% as AI ‘Neocloud’ Trade Stumbles – Despite $9.7B Microsoft Deal (14 November 2025)

IREN Limited (IREN) Stock Plunges 12% as AI ‘Neocloud’ Trade Stumbles – Despite $9.7B Microsoft Deal (14 November 2025)

IREN Limited (NASDAQ: IREN) – the Australian-born Bitcoin miner turned renewable-powered AI data‑center operator – is having another wild session on Friday, 14 November 2025. Despite landing a landmark US$9.7 billion AI cloud contract with Microsoft earlier this month and reporting record quarterly results last week, the stock is down sharply again today as investors reassess the risks behind its…
AMD’s AI Mega-Deal Sparks Stock Surge – Inside the OpenAI Partnership, New Chips & Showdown with Rivals

AMD Stock Pre-Market Today (Nov. 14, 2025): What to Know Before the US Market Opens

Key Takeaways Before the Bell This article is for information and news purposes only and is not financial advice or a recommendation to buy or sell any security. AMD Stock Pre-Market Today: Price, Move and Valuation As of early U.S. pre-market trading on Friday, November 14, 2025, AMD’s last indicated pre-market price is about $242.51, down roughly $5.45 (-2.2%) from Thursday’s close of $247.96. Pre-market volume is reported around 266,600…
Sonder Holdings (SOND) Nears Chapter 7 After Marriott Split: Stock & Bankruptcy Update for November 13, 2025

Sonder Holdings (SOND) Nears Chapter 7 After Marriott Split: Stock & Bankruptcy Update for November 13, 2025

Sonder Holdings Inc. (NASDAQ: SOND), once pitched as a tech‑driven rival to Airbnb and a partner of Marriott International, is now in full collapse mode. The company is winding down operations, expecting to file for Chapter 7 bankruptcy of its U.S. business and begin insolvency proceedings abroad, while guests around the world report being told to leave their rooms with…
Korro Bio (KRRO) Stock Crashes as Novo Nordisk Pauses Pact, KRRO‑110 Disappoints and 34% Layoffs Extend Cash Runway – What Investors Need to Know Today

Korro Bio (KRRO) Stock Crashes as Novo Nordisk Pauses Pact, KRRO‑110 Disappoints and 34% Layoffs Extend Cash Runway – What Investors Need to Know Today

Korro Bio, Inc. (NASDAQ: KRRO) is at the center of one of biotech’s biggest shake‑ups of 2025. After releasing mixed early data from its lead RNA‑editing program, KRRO‑110, the company has announced deep layoffs, a strategic pivot in its pipeline and a 12‑month pause in its high‑profile collaboration with Novo Nordisk. The stock has responded with a brutal collapse. As…
Aviva share price today (13 November 2025): stock slips ~4% after Q3 update lifts targets and Direct Line synergies

Aviva share price today (13 November 2025): stock slips ~4% after Q3 update lifts targets and Direct Line synergies

Live price snapshotAviva (LSE: AV.) traded at 664.60p at 09:53 GMT, down 28.00p (-4.04%) versus Wednesday’s close. Intraday, the stock has moved between 656.08p and 675.99p; its 52‑week range stands at 451.90p–698.40p. Figures are delayed and time‑stamped. Financial Times Markets What’s moving the sharesThe drop follows Aviva’s third‑quarter trading update and “In Focus” presentation, which raised medium‑term ambitions and nearly…
Shell’s $2 Billion Nigeria Gas Gamble Ignites LNG Boom Amid $8 B Investment Surge

Shell Stock Price Today (12 Nov 2025): SHEL ADR edges lower as oil slides; London closes at 2,909p amid fresh buyback and Volta Media sale

All figures and news items are for Wednesday, November 12, 2025. Shell stock at a glance (real‑time snapshot) Note: Each U.S. SHEL ADR represents two ordinary shares traded in London/Amsterdam. Nasdaq What moved Shell’s share price today 1) Oil prices dropped on a new OPEC outlook Crude fell sharply after an OPEC report signaled supply and demand could be broadly…
Saudi Aramco Stock Analysis 2025: Is the Oil Giant Still Worth Your Money?

Saudi Aramco Stock Today (2222): Closes at 25.96 SAR; $1bn MoUs Announced as Oil Slips — November 12, 2025

Riyadh — November 12, 2025. Saudi Aramco (Tadawul: 2222) inched higher on Wednesday, closing at 25.96 SAR, up 0.08% on the day. The move came after a soft start to the session and against a mixed backdrop for Gulf equities. Investing Price Action at a Glance (Nov 12, 2025) Figures reflect official market data for today’s session on the Saudi…
Microsoft Stock Soars on AI and Cloud Frenzy – Analysts Eye $600+ Price Targets

Microsoft (MSFT) Stock Today — Nov. 11, 2025: Shares Edge Higher as $10B Portugal AI Hub, Patch Tuesday Fixes and New Enterprise AI Deals Dominate Headlines

Updated Nov. 11, 2025 Key takeaways Market snapshot: MSFT price action Microsoft stock traded modestly higher on Tuesday, recently around $508.68, up $2.91 (~0.6%) versus the prior close. The session’s high/low printed near $509.54/$502.44, with intraday volume just under 17 million shares by late trade. Microsoft’s market capitalization hovered near $3.85 trillion, with a P/E of roughly 36.7 on trailing…
JD.L: JD Sports Edges Higher as Buyback Continues — All the News Investors Need on 11 November 2025

JD.L: JD Sports Edges Higher as Buyback Continues — All the News Investors Need on 11 November 2025

Date: 11 November 2025 JD Sports Fashion (LSE: JD., ticker JD.L) traded modestly higher today as the retailer reported another daily share repurchase under its £100m buyback. Here’s today’s price action, the fresh RNS, and the next catalysts investors should watch Quick take JD.L share price snapshot (11 Nov 2025) JD Sports shares ticked higher in London, with last trade…

Stock Market Today

  • Davide Campari-Milano Stock Forecast 2026-2030: Analyst Price Targets and Market Outlook
    January 23, 2026, 10:28 AM EST. Davide Campari-Milano (CPR) trades near €5.80 as of 16 January 2026, with steady intraday fluctuations amid ongoing portfolio streamlining and balance-sheet initiatives. Analysts forecast a moderate upside within 12 months, with average price targets ranging from €6.86 to €7.05 across MarketScreener, Fintel, and TradingView. The forecasts reflect expected valuation adjustments based on the company's focus on core brands and geographic expansion, while broader European market trends and earnings updates also influence estimates. Price targets span a wide range, from lows around €4.20 to highs up to €11.55, indicating diverse views on the stock's potential.
Go toTop